BELFAST, Irlande du Nord–(BUSINESS WIRE)–Re-Vana Therapeutics Ltd, une société privée de thérapies spécialisées et d’administration médicamenteuse développant des agents thérapeutiques à libération prolongée pour lutter contre des pathologies oculair…
Uncategorized
Riassunto: Re-Vana Therapeutics raccoglie 3,25 milioni di dollari nell'ambito di un finanziamento pre-serie A
BELFAST, Irlanda del Nord–(BUSINESS WIRE)–Re-Vana Therapeutics Ltd, una società a capitale privato che opera nel settore delle terapie speciali e della somministrazione di farmaci a rilascio prolungato per patologie oculari con significative ripercus…
Uncategorized
VIDEO: Ophthalmologists discuss reopening, how to practice safely
In the second part of a three-part video discussion, Leela V. Raju, MD, and Sonya Dhar, MD, discuss safety issues for ophthalmologists reopening clinics and what they anticipate as they return to the clinic.
Microperimetry can help determine the efficacy of novel treatments for macular diseases
Stargardt disease is an inherited eye disease. Its onset is typically in adolescence and it is among the leading causes of blindness in this age group. Symptoms range from severe loss of sharp vision to almost complete loss of sight.
Uncategorized
Glaukos Announces Participation in the William Blair 40th Annual Growth Stock Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
Uncategorized
Bausch + Lomb launches preloaded IOLs in Europe
Bausch + Lomb has launched its first extended depth of focus IOL and a new monofocal IOL in Europe.“LuxSmart and LuxGood feature an innovative premium optic design and [pure refractive optics] technology that reduces dysphotopsia, a common phenomenon t…